Sqi Diagnostics Inc (SQIDF) 0.4860 $SQIDF
SQI Diagnostics to Announce Second Quarter 2015 Results
PR Newswire - Thu May 14, 3:30PM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2015, after market close on Thursday, May 21, 2015. President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday May 22, 2015 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.480 (-0.010)
SQI Diagnostics to Extend Warrant Expiry
CNW Group - Fri Apr 17, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI" , today announced that it has received approval from the TSX Venture Exchange to extend the expiry of 5,126,044 outstanding common share purchase warrants ("the Warrants" of the Company, which were issued in connection with the Company's May 2013 private placement financing.
SQD.VN: 0.480 (-0.010)
SQI Delivers Sqidlite System to Global Pharmaceutical Customer
PR Newswire - Wed Apr 15, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI" , today announced the delivery and installation of a sqidlite(TM) system under the terms of an agreement with a top tier global pharmaceutical customer. As previously disclosed, two custom immunogenicity assays have been successfully developed for this customer.
SQD.VN: 0.480 (-0.010)
Bristol-Myers Squibb to Highlight SQI's Technology at WRIB Conference
CNW Group - Thu Apr 09, 8:00AM CDT
SQI's Strength in Immunogenicity Testing Featured In Multiple Presentations
BMY: 67.64 (+0.19), SQD.VN: 0.480 (-0.010)
SQI Announces Election of Directors
PR Newswire - Wed Apr 08, 1:32PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced the voting results for its nominees for director at its reconvened annual and special meeting of shareholders held today.
SQD.VN: 0.480 (-0.010)
SQI Diagnostics Inc. Announces Adjournment of Meeting
CNW Group - Thu Mar 26, 12:10PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF) announced that after dealing with certain matters, including the appointment of auditors, its annual and special meeting of shareholders held on March 26, 2015 (the "Meeting" was adjourned, as previously disclosed on March 25, 2015, until April 8, 2015 at 11:00 a.m. (Toronto time). The date of the reconvened Meeting has been changed from that previous disclosed. The Meeting will reconvene at the offices of the Company's counsel, Gowling Lafleur Henderson LLP, located at 100 King Street West, Suite 1600, Toronto, Ontario.
SQD.VN: 0.480 (-0.010)
SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting
PR Newswire - Wed Mar 25, 9:22PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF) announced that, as a result of recent discussions with certain shareholders representing approximately 45% of the outstanding voting common shares of the Company, after dealing with certain matters including the appointment of auditors at its annual and special meeting of shareholders on March 26, 2015 (the "Meeting" it intends to adjourn the Meeting such that the election of directors will take place when the Meeting reconvenes. The Meeting will be reconvened on April 7, 2015 at 11:00 a.m. (Toronto time) at the offices of the Company's counsel, Gowling Lafleur Henderson LLP, located at 100 King Street West, Suite 1600, Toronto, Ontario.
SQD.VN: 0.480 (-0.010)
Leading 100 medical technology companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pc3fm/usacanada) has announced the addition of the "USA/Canada Medical Technology 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Health care technology assessment is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. Most of the top medical technology companies come from the United States. In general, trends show an increasing use of medical technology products with demand expected to grow some four percent in the United States. In Canada too, the medical device advancements help save the lives of patients by improving the accuracy of diagnoses, enhancing treatments and cure of diseases, reducing long-term disabilities and helping to provide better medical care. Covering a wide range of products, medical technology examples include pacemakers, artificial heart valves, hip implants, synthetic skin, scalpels, and medical laboratory diagnostic instruments. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in the USA/Canadian medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical technology companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Key Topics Covered: Introduction Analysis Section 1. Rankings of Medical Technology Companies of USA/Canada 1.1. Leading 100 Medical Technology Companies of USA/Canada (based on recent sales, net income, total assets, total equity) 1.2. Most Growing 25 Medical Technology Companies of USA/Canada 1.3. Most Profitable 25 Medical Technology Companies of USA/Canada 2. Stock Market Performance over 5 Years. Leading 25 Medical Technology Companies of USA/Canada News Section 3. Key News of Medical Technology Sector in USA/Canada for Year 2014 3.1 - Key Company News. By Country and Company 3.2 - Key Company News. By News Category 3.3 - Key Industry News. By News Category 4. International Alliances of Medical Technology Companies in USA/Canada 5. International Presence of USA/Canadian Medical Technology Companies 6. Research and Development Activities in USA/Canadian Medical Technology Industry 7. Mergers and Acquisitions in USA/Canadian Medical Technology Industry Companies Mentioned (Partial List) - LED Medical Diagnostics Incorporated (Canada) - Masimo Corporation (United States) - Mazor Robotics Ltd (United States) - Medtronic, Incorporated (United States) - Mela Sciences Incorporation (United States) - Novation Holdings, Inc. (United States) - Oncologix Tech, Inc. (United States) - Pathfinder Cell Therapy Inc (United States) - Positron Corporation (United States) - Revolutions Medical Corporation (United States) - Rockwell Medical Incorporated (United States) - SQI Diagnostics Inc. (Canada) - The Cooper Companies, Inc. (United States) - Titan Medical Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/7pc3fm/usacanada
MASI: 34.63 (unch), MDT: 76.42 (+0.16), MZOR: 11.85 (+0.16)
SQI Diagnostics to Announce First Quarter 2015 Results
PR Newswire - Thu Feb 19, 8:05AM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the quarter-ended December 31, 2014, after market close on Thursday, February 26, 2015.
O: 47.90 (+0.59), SQD.VN: 0.480 (-0.010)
SQI Diagnostics Completes Tranche of Debenture Financing
CNW Group - Fri Jan 30, 2:01PM CST
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has closed the first tranche of its previously announced non-brokered private placement (the "Offering" of secured debentures for gross proceeds of $1.95 million.
SQD.VN: 0.480 (-0.010)
SQI Diagnostics Announces Debt Financing of up to $4 Million
CNW Group - Wed Jan 21, 3:53PM CST
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES.
SQD.VN: 0.480 (-0.010)
SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results
CNW Group - Wed Dec 17, 3:05PM CST
Solid Customer Growth Positions for Revenue Velocity in 2015
SQD.VN: 0.480 (-0.010)
SQI Diagnostics to Announce Second Quarter 2015 Results
PR Newswire - Thu May 14, 3:30PM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2015, after market close on Thursday, May 21, 2015. President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday May 22, 2015 at 10:00 a.m. ET to review financial results and discuss business developments for the period. SQD.VN: 0.480 (-0.010)
SQI Diagnostics to Extend Warrant Expiry
CNW Group - Fri Apr 17, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI"
, today announced that it has received approval from the TSX Venture Exchange to extend the expiry of 5,126,044 outstanding common share purchase warrants ("the Warrants" of the Company, which were issued in connection with the Company's May 2013 private placement financing. SQD.VN: 0.480 (-0.010)
SQI Delivers Sqidlite System to Global Pharmaceutical Customer
PR Newswire - Wed Apr 15, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI"
, today announced the delivery and installation of a sqidlite(TM) system under the terms of an agreement with a top tier global pharmaceutical customer. As previously disclosed, two custom immunogenicity assays have been successfully developed for this customer. SQD.VN: 0.480 (-0.010)
Bristol-Myers Squibb to Highlight SQI's Technology at WRIB Conference
CNW Group - Thu Apr 09, 8:00AM CDT
SQI's Strength in Immunogenicity Testing Featured In Multiple Presentations
BMY: 67.64 (+0.19), SQD.VN: 0.480 (-0.010)
SQI Announces Election of Directors
PR Newswire - Wed Apr 08, 1:32PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced the voting results for its nominees for director at its reconvened annual and special meeting of shareholders held today. SQD.VN: 0.480 (-0.010)
SQI Diagnostics Inc. Announces Adjournment of Meeting
CNW Group - Thu Mar 26, 12:10PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF) announced that after dealing with certain matters, including the appointment of auditors, its annual and special meeting of shareholders held on March 26, 2015 (the "Meeting" was adjourned, as previously disclosed on March 25, 2015, until April 8, 2015 at 11:00 a.m. (Toronto time). The date of the reconvened Meeting has been changed from that previous disclosed. The Meeting will reconvene at the offices of the Company's counsel, Gowling Lafleur Henderson LLP, located at 100 King Street West, Suite 1600, Toronto, Ontario. SQD.VN: 0.480 (-0.010)
SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting
PR Newswire - Wed Mar 25, 9:22PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF) announced that, as a result of recent discussions with certain shareholders representing approximately 45% of the outstanding voting common shares of the Company, after dealing with certain matters including the appointment of auditors at its annual and special meeting of shareholders on March 26, 2015 (the "Meeting" it intends to adjourn the Meeting such that the election of directors will take place when the Meeting reconvenes. The Meeting will be reconvened on April 7, 2015 at 11:00 a.m. (Toronto time) at the offices of the Company's counsel, Gowling Lafleur Henderson LLP, located at 100 King Street West, Suite 1600, Toronto, Ontario. SQD.VN: 0.480 (-0.010)
Leading 100 medical technology companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pc3fm/usacanada) has announced the addition of the "USA/Canada Medical Technology 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Health care technology assessment is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. Most of the top medical technology companies come from the United States. In general, trends show an increasing use of medical technology products with demand expected to grow some four percent in the United States. In Canada too, the medical device advancements help save the lives of patients by improving the accuracy of diagnoses, enhancing treatments and cure of diseases, reducing long-term disabilities and helping to provide better medical care. Covering a wide range of products, medical technology examples include pacemakers, artificial heart valves, hip implants, synthetic skin, scalpels, and medical laboratory diagnostic instruments. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in the USA/Canadian medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical technology companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Key Topics Covered: Introduction Analysis Section 1. Rankings of Medical Technology Companies of USA/Canada 1.1. Leading 100 Medical Technology Companies of USA/Canada (based on recent sales, net income, total assets, total equity) 1.2. Most Growing 25 Medical Technology Companies of USA/Canada 1.3. Most Profitable 25 Medical Technology Companies of USA/Canada 2. Stock Market Performance over 5 Years. Leading 25 Medical Technology Companies of USA/Canada News Section 3. Key News of Medical Technology Sector in USA/Canada for Year 2014 3.1 - Key Company News. By Country and Company 3.2 - Key Company News. By News Category 3.3 - Key Industry News. By News Category 4. International Alliances of Medical Technology Companies in USA/Canada 5. International Presence of USA/Canadian Medical Technology Companies 6. Research and Development Activities in USA/Canadian Medical Technology Industry 7. Mergers and Acquisitions in USA/Canadian Medical Technology Industry Companies Mentioned (Partial List) - LED Medical Diagnostics Incorporated (Canada) - Masimo Corporation (United States) - Mazor Robotics Ltd (United States) - Medtronic, Incorporated (United States) - Mela Sciences Incorporation (United States) - Novation Holdings, Inc. (United States) - Oncologix Tech, Inc. (United States) - Pathfinder Cell Therapy Inc (United States) - Positron Corporation (United States) - Revolutions Medical Corporation (United States) - Rockwell Medical Incorporated (United States) - SQI Diagnostics Inc. (Canada) - The Cooper Companies, Inc. (United States) - Titan Medical Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/7pc3fm/usacanada
MASI: 34.63 (unch), MDT: 76.42 (+0.16), MZOR: 11.85 (+0.16)
SQI Diagnostics to Announce First Quarter 2015 Results
PR Newswire - Thu Feb 19, 8:05AM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the quarter-ended December 31, 2014, after market close on Thursday, February 26, 2015. O: 47.90 (+0.59), SQD.VN: 0.480 (-0.010)
SQI Diagnostics Completes Tranche of Debenture Financing
CNW Group - Fri Jan 30, 2:01PM CST
SQI Diagnostics Inc. ("SQI" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has closed the first tranche of its previously announced non-brokered private placement (the "Offering" of secured debentures for gross proceeds of $1.95 million. SQD.VN: 0.480 (-0.010)
SQI Diagnostics Announces Debt Financing of up to $4 Million
CNW Group - Wed Jan 21, 3:53PM CST
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES.
SQD.VN: 0.480 (-0.010)
SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results
CNW Group - Wed Dec 17, 3:05PM CST
Solid Customer Growth Positions for Revenue Velocity in 2015
SQD.VN: 0.480 (-0.010)
